197 related articles for article (PubMed ID: 24128347)
1. The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase.
Maciejak A; Leszczynska A; Warchol I; Gora M; Kaminska J; Plochocka D; Wysocka-Kapcinska M; Tulacz D; Siedlecka J; Swiezewska E; Sojka M; Danikiewicz W; Odolczyk N; Szkopinska A; Sygitowicz G; Burzynska B
BMC Biotechnol; 2013 Aug; 13():68. PubMed ID: 24128347
[TBL] [Abstract][Full Text] [Related]
2. Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations.
Prueksaritanont T; Ma B; Tang C; Meng Y; Assang C; Lu P; Reider PJ; Lin JH; Baillie TA
Br J Clin Pharmacol; 1999 Mar; 47(3):291-8. PubMed ID: 10215754
[TBL] [Abstract][Full Text] [Related]
3. Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase.
Göbel A; Pählig S; Motz A; Breining D; Traikov S; Hofbauer LC; Rachner TD
Biochem Biophys Res Commun; 2024 May; 710():149841. PubMed ID: 38588613
[TBL] [Abstract][Full Text] [Related]
4. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.
Dimitroulakos J; Marhin WH; Tokunaga J; Irish J; Gullane P; Penn LZ; Kamel-Reid S
Neoplasia; 2002; 4(4):337-46. PubMed ID: 12082550
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer.
Göbel A; Zinna VM; Dell'Endice S; Jaschke N; Kuhlmann JD; Wimberger P; Rachner TD
BMC Cancer; 2020 Jul; 20(1):703. PubMed ID: 32727400
[TBL] [Abstract][Full Text] [Related]
6. Effect of levels of acetate on the mevalonate pathway of Borrelia burgdorferi.
Van Laar TA; Lin YH; Miller CL; Karna SL; Chambers JP; Seshu J
PLoS One; 2012; 7(5):e38171. PubMed ID: 22675445
[TBL] [Abstract][Full Text] [Related]
7. The SUD1 gene encodes a putative E3 ubiquitin ligase and is a positive regulator of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in Arabidopsis.
Doblas VG; Amorim-Silva V; Posé D; Rosado A; Esteban A; Arró M; Azevedo H; Bombarely A; Borsani O; Valpuesta V; Ferrer A; Tavares RM; Botella MA
Plant Cell; 2013 Feb; 25(2):728-43. PubMed ID: 23404890
[TBL] [Abstract][Full Text] [Related]
8. Biphasic regulation of HMG-CoA reductase expression and activity during wound healing and its functional role in the control of keratinocyte angiogenic and proliferative responses.
Schiefelbein D; Goren I; Fisslthaler B; Schmidt H; Geisslinger G; Pfeilschifter J; Frank S
J Biol Chem; 2008 May; 283(22):15479-90. PubMed ID: 18390541
[TBL] [Abstract][Full Text] [Related]
9. The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.
Blankier S; McCrindle BW; Ito S; Yeung RS
Clin Exp Immunol; 2011 May; 164(2):193-201. PubMed ID: 21361911
[TBL] [Abstract][Full Text] [Related]
10. Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma.
Tran GB; Ding J; Ye B; Liu M; Yu Y; Zha Y; Dong Z; Liu K; Sudarshan S; Ding HF
Cancer Res; 2023 Jul; 83(13):2248-2261. PubMed ID: 37057874
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide and CCAAT/enhancer-binding protein transcription factor in statin-dependent induction of heme oxygenase-1 in mouse macrophages.
Mouawad CA; Mrad MF; Al-Hariri M; Soussi H; Hamade E; Alam J; Habib A
PLoS One; 2013; 8(5):e64092. PubMed ID: 23717538
[TBL] [Abstract][Full Text] [Related]
12. Geranylgeranyl pyrophosphate is a potent regulator of HRD-dependent 3-Hydroxy-3-methylglutaryl-CoA reductase degradation in yeast.
Garza RM; Tran PN; Hampton RY
J Biol Chem; 2009 Dec; 284(51):35368-80. PubMed ID: 19776008
[TBL] [Abstract][Full Text] [Related]
13. Regulation of HMG-CoA reductase degradation requires the P-type ATPase Cod1p/Spf1p.
Cronin SR; Khoury A; Ferry DK; Hampton RY
J Cell Biol; 2000 Mar; 148(5):915-24. PubMed ID: 10704442
[TBL] [Abstract][Full Text] [Related]
14. Targeting Enterococcus faecalis HMG-CoA reductase with a non-statin inhibitor.
Bose S; Steussy CN; López-Pérez D; Schmidt T; Kulathunga SC; Seleem MN; Lipton M; Mesecar AD; Rodwell VW; Stauffacher CV
Commun Biol; 2023 Apr; 6(1):360. PubMed ID: 37012403
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Decrease the Growth, Ergosterol Synthesis and Generation of
Andrade-Pavón D; Sánchez-Sandoval E; Tamariz J; Ibarra JA; Hernández-Rodríguez C; Villa-Tanaca L
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069194
[No Abstract] [Full Text] [Related]
16. Metabolically regulated endoplasmic reticulum-associated degradation of 3-hydroxy-3-methylglutaryl-CoA reductase: evidence for requirement of a geranylgeranylated protein.
Leichner GS; Avner R; Harats D; Roitelman J
J Biol Chem; 2011 Sep; 286(37):32150-61. PubMed ID: 21778231
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo.
Pereira M; Glogova A; Haagsma J; Stewart J; Shepherd TG; Petrik J
J Ovarian Res; 2023 Nov; 16(1):218. PubMed ID: 37986175
[TBL] [Abstract][Full Text] [Related]
18. The potential of R. toruloides mevalonate pathway genes in increasing isoprenoid yields in S. cerevisiae: Evaluation of GGPPS and HMG-CoA reductase.
Adusumilli SH; Dabburu GR; Kumar M; Arora P; Chattopadhyaya B; Behera D; Bachhawat AK
Enzyme Microb Technol; 2024 Mar; 174():110374. PubMed ID: 38147781
[TBL] [Abstract][Full Text] [Related]
19. Conserved statin-mediated activation of the p38-MAPK pathway protects Caenorhabditis elegans from the cholesterol-independent effects of statins.
Goncalves IL; Tal S; Barki-Harrington L; Sapir A
Mol Metab; 2020 Sep; 39():101003. PubMed ID: 32339771
[TBL] [Abstract][Full Text] [Related]
20. Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense.
Gabor KA; Fessler MB
Curr Mol Pharmacol; 2017; 10(1):27-45. PubMed ID: 26758950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
